1Hu DY, Pan CY, Yu JM. The relationship between coronary artery diseaseand and abnormal glucose regulation in China: the China Heart Survey [ J ]. Eur Heart J, 2006,27 ( 21 ) : 2573 - 2579.
2Shaohui Huang, Michael P Czech. The GLUT4 Glucose Transporter[ J ]. Cell Metabolism, 2007,5 (4) :237 - 252.
6Schrauwen P. High-fat diet, muscular lipotoxieity and insulin resistance [ J]. Proceedings of the Natrition Sociely, 2007,66 ( 1 ) : 33 -41.
7Ye J. Role of insulin in the pathogenesis of free fatty acid insulin resistance in skeletal muscle [ J ]. Endocr Metab Immune Disord Drug Targets ,2007,7 ( 1 ) :65 - 74.
8Amer P. Insulin resistance in type 2 diabetes-role of the adipokines[ J]. Curr Mol Med,2005, 5 : 333 -339.
9Saha AK, Ruderman NB. Malonyl-CoA and AMP-activated protein kinase : an expanding partnership [ J ]. Mol Cell Biochem, 2003,253:65 - 70.
10Namkoong C, Kim MS, Jang PG,et al. The insulinotropic effet of steviated protein kinase activity contributes to hyperphagia in diabetic rats [ J ]. Diabetes, 2005,54 : 63 - 68.
9Kolobova E, Tuganova A, Boulatnikov I, et al. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites[J]. Biochem J, 2001, 358 (Pt 1) :69 - 77.
10Degenhardt T, Saramaki A, Malinen M, et al. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta[J]. J Mol Biol, 2007, 372(2) :341 - 255.
8Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and and abnormal 0ucose regulation in China: the china Heart Survey[J]. Eur Heart J, 2006, 27(21): 2573 -2579.
9W. C. Stanley. Changes in cardiac metabolism: a critical step from stable angina to ischemic cardiomyopathy [J]. EurHeart J Supplements, 2001, 3(Suppl) : 2-7.
10Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long -chain 3- ketoacyl coenzyme A thiolase [J]. Circ Res, 2000, 86(5) : 580-588.
